Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TP53 |
| Variant | G245C |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | TP53 G245C is a hotspot mutation that lies within the DNA binding domain of the Tp53 protein (PMID: 22713868). G245C results in a loss of transactivation of several targets of wild-type Tp53 (PMID: 22170099, PMID: 30126368), and also confers a gain of function to Tp53, as demonstrated through inhibition of Ampk activation in cell culture, and leads to increased tumor formation in mouse models (PMID: 24857548), and increased migration and invasion in culture (PMID: 30126368). |
| Associated Drug Resistance | |
| Category Variants Paths |
TP53 mutant TP53 exon7 TP53 G245C TP53 mutant TP53 inact mut TP53 G245C |
| Transcript | NM_000546.6 |
| gDNA | chr17:g.7674230C>A |
| cDNA | c.733G>T |
| Protein | p.G245C |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001126112.2 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001126113.3 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001126114.2 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_000546.5 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_000546.6 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001126112.3 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001407266.1 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001126112 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_000546 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001126113.2 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001126114.3 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001407270.1 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001126113 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001407268.1 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001407264.1 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001126114 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| NM_001407262.1 | chr17:g.7674230C>A | c.733G>T | p.G245C | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|